Back to search
FDAFDA · Food and drugs·Recall number D-0099-2023

Rocuronium Bromide Injection, 50 mg/5 mL (10 mg/mL), 5 x 5 mL Pre-Filled Syringe, 6 x 5 syringe carton, Rx Only, Nephron 503B outsourcing facility, 4500 12th Street Extension, West Columbia, SC 29172, NDC: 69374-924-05

Published January 18, 2023 · Recall initiated: January 6, 2023

Summary

FDA records drug Class II recall D-0099-2023, published January 18, 2023 and initiated January 6, 2023. Recalling firm: Nephron Sterile Compounding Center LLC; Status: Terminated; Reported quantity: 38,830 syringes; Lot: Lot: RC2011A, Exp. 2/22/2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Nephron Sterile Compounding Center LLC
Distributor
Nationwide in the USA.
Lot
Lot: RC2011A, Exp. 2/22/2023
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Rocuronium Bromide Injection, 50 mg/5 mL (10 mg/mL), 5 x 5 mL Pre-Filled Syringe, 6 x 5 syringe carton, Rx Only, Nephron 503B outsourcing facility, 4500 12th Street Extension, West Columbia, SC 29172, NDC: 69374-924-05 recalled?

Yes. FDA published recall D-0099-2023 on January 18, 2023. Reported hazard: Lack of Assurance of Sterility

What should I do if I have this product?

Voluntary: Firm initiated · Letter